DUBLIN, November 3, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "US Market Report for Anti-Reflux Devices 2017 - MedCore" report to their offering.
In 2013, after a remodeling and design of their device, Mederi Therapeutics increased its marketing activities, facilitating its market penetration and unit sales. Such campaigns will continue to enable customer education and patient and surgeon outreach, increasing public awareness about the products and procedures available. Furthermore, as more literature that supports these procedures becomes available, the number of insurance carriers providing coverage will increase, driving unit sales further. Other emerging competitors, such as Medigus and EndoStim, will also augment the market by providing more options and expanding potential patient education. Following the exit of NDO Surgical, Curon Medical and C.R. Bard in the past, EndoGastric Solution was left to fill the void left by these companies. Utilizing an aggressive marketing campaign and a large sales expansion, the company was able to increase its market presence significantly. However, since then, two other companies have entered the market to compete for market share: Mederi Therapeutics which acquired Curon Medical and its Stretta® system after it filed for bankruptcy in 2010, and Torax Medical which received FDA approval for its LINX® system in 2012. Key Topics Covered: 1. Executive Summary U.S. Gastrointestinal Endoscopic Device Market Overview Competitive Analysis Market Trends Market Developments Procedure Numbers Procedure Codes Investigated Markets Included 2. Disease Overview 2.1 Basic Anatomy 2.2 Gastrointestinal Disease: Treatment And Diagnostics 2.2.1 Gastro-Esophageal Reflux Disease (GERD) 2.2.2 Barrett's Esophagus 2.2.3 Digestive Cancer 2.2.4 Gastrointestinal Bleeding 2.2.5 Bile Duct Disorders 2.2.6 Crohn'S Disease